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In recent years the role of extracellular vesicles (EVs) of Gram‑positive bacteria in host‑microbe cross‑
talk has become increasingly appreciated, although the knowledge of their biogenesis, release and 
host‑uptake is still limited. The aim of this study was to characterize the EVs released by the dairy 
isolate Lactiplantibacillus plantarum BGAN8 and to gain an insight into the putative mechanism of 
EVs uptake by intestinal epithelial cells. The cryo‑TEM observation undoubtedly demonstrated the 
release of EVs (20 to 140 nm) from the surface of BGAN8, with exopolysaccharides seems to be part of 
EVs surface. The proteomic analysis revealed that the EVs are enriched in enzymes involved in central 
metabolic pathways, such as glycolysis, and in membrane components with the most abundant 
proteins belonging to amino acid/peptide ABC transporters. Putative internalization pathways were 
evaluated in time‑course internalization experiments with non‑polarized HT29 cells in the presence 
of inhibitors of endocytic pathways: chlorpromazine and dynasore (inhibitors of clathrin‑mediated 
endocytosis—CME) and filipin III and nystatin (disrupting lipid rafts). For the first time, our results 
revealed that the internalization was specifically inhibited by dynasore and chlorpromazine but not 
by filipin III and nystatin implying that one of the entries of L. plantarum vesicles was through CME 
pathway.
Archaea, Bacteria and Eukarya produce and release extracellular vesicles (EVs) that are membrane-contained 
structures playing a relevant role in the inter-communications established among these tree domains of life; 
however, there are still many unsolved questions on this  field1. Firstly, nomenclature is sometimes confusing. 
In eukaryotic cells it can be broadly classified as: microvesicles (microparticles or ectosomes) that are produced 
from the cytoplasmatic membrane; exosomes, intracellularly formed through endosomes and released upon 
fusion with the cytoplasmatic membrane; and apoptotic bodies which are released from apoptotic  cells2. In the 
case of bacteria, most studies have been performed with Gram-negatives and two types of bacterial EVs have 
been described: outer membrane vesicles (OMVs), derived from outer membrane that enclose periplasmic 
components, and outer-inner membrane vesicles (O-IMVs) formed by the protrusion of both, outer and cyto-
plasmic, membranes that could be enriched in cytoplasmic  components3,4. Extracellular vesicles in Gram-positive 
bacteria have been purified more recently, and mostly in pathogenic  species5,6. They are collectively referred as 
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bacterial EVs or membrane vesicles (MV); however some authors propose the name of cytoplasmic (CMVs)7, 
whereas others use the term MV to refer to empty vesicles, for example right side-out and inside-out MV from 
Escherichia coli applied for studying mechanism of transport in different  bacteria8. In this work, dealing with 
the characterization of vesicles produced by Lactiplantibacillus plantarum (formerly Lactobacillus plantarum), 
we will use the term EVs.
The biogenesis and release of bacterial EVs is not well understood. In Gram negatives two mechanisms have 
been proposed: “blebbing of ” membrane material of living cells and endolysin-triggered cell  lysis7. For Gram-
positives the picture is even more unclear, and most studies have been carried out in Bacillus subtillis and Staphy-
lococcus aureus, since the release of EVs seems to be involved in their  pathogenicity7,9. It has been proposed that 
an endolysin (prophage encoded) triggers the protrusion and release of EVs through a hole in the peptidoglycan 
of B. subtilis which, although does not provoke its lysis, weaken the cells due to the loss of membrane  integrity10; 
this process is known as “bubbling cell death” and is not exclusive of this  bacterium7. In the case of S. aureus, 
phenol-soluble modulins are required for the release of EVs because these peptides facilitate an increase in the 
fluidity of the cytoplasmic  membrane11. Indeed, the modulins are also involved in the recognition of EVs by 
TLR (toll-like-receptor)-2 located in the surface of the host cells, which is one of the mechanisms described for 
bacterial EVs uptake and  internalization12,13.
One of the intriguing questions that had promoted a lot of research is what the bacterial EVs carry out inside. 
In fact, thinking from a human perspective, they have been proposed as “cargo” structures that harbour differ-
ent molecules of pivotal relevance for the interaction with the host, both in negative (pathogenesis) or positive 
 ways14. Just to summarize some of the most recent studies, it has been showed that EVs released by probiotics 
are able to interact with pattern recognition receptors (PRR) of host cells initiating the downstream immune 
response modulation which, contrary to that induced by pathogens (pro-inflammatory) is more  tolerogenic15–18. 
Additionally, EVs released by L. plantarum were able to in vivo regulate the brain function being able to reduce 
the stress-induced depression in  mice19. Therefore, the EVs released by probiotics, or by the intestinal micro-
biota, could have multiple applications on human  health6,20,21. Indeed, bioengineering bacterial EVs produced by 
commensal bacteria has been proposed as a putative method for the delivery of biotherapeutics to the intestinal 
 tract22. Finally, another open question in this field, related to the purification of bacterial EVs within a pool of 
eukaryotic EVs from human body fluids has been recently  addressed23, which will open an avenue for research 
on the application of these cargo vehicles.
Recently, it has been reported the isolation and proteomic characterization of Lactobacillus-derived EVs 
vesicles from three strains of the probiotic species L. casei, L. acidophilus and L. reuteri24. The aim in the current 
work is to achieve the characterization of the EVs released by the potential probiotic L. plantarum BGAN8, an 
exopolysaccharide (EPS) producing strain, as well as, given the scarce information about the internalization 
pathways in Gram-positives, to gain insight about the putative mechanism of probiotic EVs uptake by intestinal 
epithelial cells.
Results
Microscopic analyses. The observation of L. plantarum BGAN8 using different microscopy techniques 
revealed the presence of EVs in its surface as showed in Fig. 1 (see supplementary Figs. S1, S2 and S3). The pres-
ence of an EPS layer surrounding the cell somehow difficult the detection of a defined contour of the exocellular 
formation by means of TEM (Fig. 1A), contrary to that observed for other  strains25. However, in a closer view 
of the bacterial surface (Fig. S1) it was possible to detect a rounded protrusion, darker than the EPS layer and 
showing a rough aspect, probably, due to the presence of the polymer; the size seems to be smaller than 100 nm. 
The SEM images obtained (Fig. 1B, Fig. S2) also denoted the presence of small “dots”, being some of them shinier 
than the rest of the  surface25. Nevertheless, the cryo-SEM observation, the less invasive technique that only 
involves the liquid  N2 frozen of the bacterial suspension, undoubtedly revealed the presence of small EVs in the 
surface of this EPS-producing strain, as well as clearly showed the presence of a polymer loosely attached to the 
cell (Fig. 1C, S3).
The next approach was to purify this material from viable BGAN8 cultures (supplementary Fig. S8) using 
standard procedures described in literature. The pellet obtained (Fig. S4) resembles that previously  reported26 
but, in our case, the EVs sediment obtained after ultracentrifugation was very viscous, thus suggesting the co-
precipitation of part of the tightly EPS-attached layer, as it was pointed in the TEM analysis (Fig. S1). To check 
the presence of EVs, this pellet was submitted to cryo-SEM analysis; however, the small size of the particles, 
very near to the resolution level of the equipment used, and the presence of the EPS in the sample difficult the 
obtaining of good resolution images. Nevertheless, it was possible to detect an EPS network with small spherical 
particles imbed inside; this suggests that the polymer also form part of the surface of the EVs (Fig. S5). Finally, 
the cryo-TEM technique was applied as a close-to-native state visualization due to minimal sample manipula-
tion. EVs samples were vitrified by rapid immersion in ethane and directly visualized by cryo-microscopy at 
liquid nitrogen temperatures in the absence of any added contrast  agent3. This analysis revealed the presence of 
a single layer of EVs that can be found as separate structures (Fig. 2A) or as small groups of vesicles trapped in 
an undefined network of, probably, EPS (Fig. S6). The EVs of L. plantarum BGAN8 displayed a homogeneous, 
spherical morphology with size that ranged from 20 to 140 nm. Indeed, the size distribution of EVs (Fig. 2B) 
showed the highest abundance (43.8%) in the range between 41 and 60 nm, followed by 20–40 nm (about 20%), 
and the remaining (about 36%) with a bigger size (between 61 and 140 nm). In spite of the scarce available data, 
we consider that this size distribution is similar to that reported in literature for bacterial EVs of lactobacilli 
 strains25–28, specifically for L. plantarum19,29, whereas the reported range of EVs from pathogenic Gram-positive 
bacteria seems to be slightly higher, between 10 and 400 nm6.
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Proteomic analyses. To undertake a preliminary characterisation of the L. plantarum BGAN8 EVs, its 
proteomic profile was analysed. Firstly, a SDS-PAGE study of EVs extracted from supernatants of three inde-
pendent cultures, and the corresponding whole protein fractions obtained from the bacterial pellets, was per-
formed. Results obtained revealed a different protein profile of EVs with respect to the whole protein content of 
the bacterium, being the three replicates very reproducible among them (Fig. 3A). Five major EV protein bands 
(identified in the SDS-PAGE gel from 1 to 5) were excised, analysed by MALDI-TOF mass spectrometry and 
identified by comparison against the NCBIprot non-redundant database, resulting in the identified proteins pre-
sented in the Table of Fig. 3A. It is noticeable that the most abundant bands corresponded with amino acid / pep-
tide ABC transporters (bands 2 and 4) and with type I glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 
bands 3 and 5). These suggest that the EVs are enriched in membrane components as well as enzymes involved in 
central metabolic pathways such as glycolysis. In this regard, it has been previously reported the “moonlighting” 
function (or multifunctionality) of some of glycolytic enzymes which can be present in the surface of lactobacilli 
thus being involved in other physiological events; in the case of GAPDH, it could be involved in the adhesion of 
L. plantarum to the intestinal  epithelium30.
Figure 1.  Visualization of L. plantarum BGAN8 by different electron microscopy techniques. (A) Transmission 
electron microscopy (bar 0.5 μm). (B) Scanning electron microscopy (bar 1 μm). (C) Cryo-scanning electron 
microscopy (bar 1 μm). The red arrows show the EPS covering the surface of the strain and the yellow arrows 
underline the presence of EVs. For additional microphotographs see supplementary material.
4
Vol:.(1234567890)
Scientific Reports |        (2020) 10:21829  | https://doi.org/10.1038/s41598-020-78920-z
www.nature.com/scientificreports/
Next, the triplicates of each fraction (bacterial pellet or EVs) obtained from three independent cultures of L. 
plantarum BGAN8 were mixed and analysed by means of LC–MS/MS for peptide profiling and further protein 
identification. Results obtained are available as supplementary material (see Database of protein fingerprint.
xlsx). The number of total proteins identified was 1387 of which, 979 where common in both fractions whereas 
238 where exclusively present in the BGAN8 whole-fraction and 170 in the EVs fraction. Of the total proteins, 
biological functions were assigned for about 59% (820 proteins), whilst the subcellular location (cellular compo-
nent) was assigned for approximately 33% (455 proteins). Figure 3B shows a summary of the cellular component 
and the biological process of proteins with these two characteristics assigned after the analysis of the raw data 
(see supplementary methods for details). Regarding the cellular location, 331 proteins were shared between 
both fractions and, remarkably, 82 were exclusively present in the EVs fraction while 42 were only found in the 
whole protein bacterial one (Fig. 3B, left panel up). It is noticeable that, among the proteins with cellular location 
assigned and exclusively present in the EVs (Fig. 3B, right panel up), most of them by far (91.5%) corresponded 
with a membrane location, whereas 28.6% had a membrane location in the proteins exclusively found in the 
whole protein fraction. This could be expected taking into account the putative way of bacterial EV formation 
and release through the cell  wall5. In the case of the whole bacterial-fraction, most of the exclusive proteins 
corresponded with those located in the cytoplasm (64.3%). The analysis of the proteins with biological process 
assigned showed that 614 were common between both fractions and, in this case, the whole bacterial-fraction 
Figure 2.  Extracellular vesicles purified from L. plantarum BGAN8 cell-free supernatants. (A) EVs visualized 
by cryo-transmission electron microscopy (bar 200 nm); size of the particles (from up to bottom and left to 
right): 115.2 nm, 69.5 nm, 91.3 nm and 40.6 nm). (B) Size distribution of the EVs according to the diameter 
range (nm) measured under the cryo-TEM microscope.
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Figure 3.  Proteomic fingerprint of the whole cell-extract and the EVs from L. plantarum BGAN8. (A) SDS-
PAGE profile of three culture replicates (A, B, and C) of EVs and BGAN8 whole-extract. Protein identification 
(table) of some excised bands (1 to 5) was performed by a MALDI-TOF mass spectrometer and comparison 
against the NCBIprot non-redundant database. (B) Peptide fingerprint analysis performed by liquid 
chromatography and mass spectrometry. After protein identification (see supplementary data file ), the proteins 
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presented higher number (130) of exclusive proteins with known function than those (76) found only in the EVs 
fraction (Fig. 3B, left panel down). Of the exclusive assignation, most of the proteins were involved in metabolic 
processes (76.9% and 56.6% for whole bacterial-fraction and EVs, respectively) (Fig. 3B, right panel down); but, 
the EV fraction was near 4-times richer in proteins related to transport functions than the whole-extract (30.3% 
and 7.7%, respectively). The coherent results obtained, either regarding the cellular location or the biological 
function, support the fact that EVs released by L. plantarum BGAN8 were mainly enriched in membrane com-
ponents with a high fraction of proteins involved in transport.
Internalization by HT29 cell line. Bacterial EVs have been proposed as delivery cargo of molecules 
involved in the bacteria-gut interaction, which could play a role on intestinal health and  homeostasis6. Given 
that the intestinal epithelium is the first physical barrier that gut bacteria encounter, we have tested the response 
of HT29-cell monolayers in the presence of UV-inactivated L. plantarum BGAN8 pellets or different concentra-
tions (determined by protein content) of the purified EVs. The real time monitoring of HT29 evolution after 
these treatments did not show any noticeable change in the impedance signal, thus indicating that there are no 
toxic effects nor detectable morphological and/or membrane-activity changes (Fig. S7).
In order to check whether the EVs from L. plantarum BGAN8 were able to interact with these enterocyte-
like cells, putative internalization pathways were evaluated using a spectrofluorometric technique. To do that, 
HT29 monolayers (at least 80% confluence) were incubated with rhodamine B-R18-labeled EVs (1 μg/well), 
and the kinetics of EVs uptake were monitored over 5 h (Fig. 4A). Results indicated that L. plantarum EVs were 
internalized in HT29 cells since a time-dependent increase in fluorescence was observed when the enterocytes 
were incubated with EVs, but not in the control cells (no EVs added) or rhodamine-labelled EVs alone (no HT29 
presence) (Fig. 4A, left panel). To identify the entry pathway of L. plantarum EVs in HT29 cells, time-course 
internalization experiments were performed in the presence of inhibitors of several endocytic pathways. Specifi-
cally, the cholesterol-sequestering agent’s filipin III and nystatin were used to disrupt lipid rafts microdomains 
and caveolae, whereas chlorpromazine and dynasore were used to inhibit clathrin-mediated endocytosis (CME). 
HT29 cells were pre-incubated for 1 h with these inhibitors and, afterwards, lactobacilli EVs uptake was measured 
by the increase in the fluorescence emitted by HT29 cells upon rhodamine-labelled EVs addition. Internalization 
was inhibited by chlorpromazine and dynasore but not by filipin III or nystatin (Fig. 4A, right panels). These 
results support that entry of L. plantarum vesicles was through CME and that cholesterol-enriched lipid rafts 
seems not to be required for this process.
Additionally, internalization of L. plantarum EVs by HT29 cells was also analysed by confocal fluorescence 
microscopy after 1 and 4 h of co-incubation. To confirm the internalization route, parallel assays were performed 
in the presence of dynasore and nystatin. For these studies, rhodamine-labelled EVs were used at 1 μg/well (red), 
HT29 nuclei were labelled with DAPI (blue) and plasma membranes with WGA (green) (Fig. 4B). In the absence 
of endocytosis inhibitors, EVs were visualized mainly adhered to the surface of HT29 cells after 1 h incuba-
tion; at this time the green signal of the HT29 membranes was not observed, probably because EPS-trapped 
vesicles adhered to the cell membrane impaired proper visualization or labelling of the HT29 membrane. After 
4 h-incubation, the red fluorescence was observed inside the cytoplasm suggesting that L. plantarum EVs were 
taken up by HT29 cells; at this time, the HT29 membrane was visualized given that EPS would not interfere with 
the signal (Fig. 4B, no inhibitor). Microscopy analysis also confirmed the effect of endocytosis inhibitors on EVs 
internalization. As shown in Fig. 4B, internalization of rhodamine-labelled EVs in HT29 cells was specifically 
inhibited by dynasore (no red signal inside the cytoplasm), whereas nystatin had no effect. These results are 
consistent with the CME pathway demonstrated by the spectrofluorometric technique.
Discussion
Lactiplantibacillus plantarum BGAN8 is a natural isolate from an artisanal cheese originated from Andrijevica 
municipality, eastern Montenegro. It was selected for this study due to its probiotic potential and to the safety 
QPS status (Qualified Presumption of Safety) of this species listed by the EFSA (European Food Safety Authority; 
EFSA)31. Among the characteristics that could be involved in its health benefits, the synthesis of an EPS as well 
as the production of γ-aminobutyric acid (GABA) (unpublished data) could be underlined. In this regard, it has 
been previously reported that EPSs produced by LAB, such as some lactobacilli species, and bifidobacteria have 
been associated with probiotic  attributes32–34, while our recent data indicated that GABA producing lactobacilli 
play a significant role in reduction of  inflammation35. Here we aimed to further characterize this strain study-
ing its capability to in vitro release EVs and to interact with intestinal epithelial cells as putative mechanisms 
involved in the bacterial-host cross-talk.
L. plantarum BGAN8 release EVs enriched in membrane transporters. In this work we have dem-
onstrated that the EPS-producing L. plantarum BGAN8 strain is able to release extracellular vesicles after 20 h of 
cultivation in MRS, which corresponded with early stationary phase, being the polymer one of the components 
of the vesicles. The most valuable technique to visualize the presence of these EVs, both purified or located in 
the surface of the bacteria, involved the use of cryo-electron microscopy (cryo-TEM and cryo-SEM) in which 
the samples were visualized almost intact after liquid  N2 congelation. In addition, the cryo-SEM allowed dem-
onstrating the production of EPS which can be easily lost during the fixation, and centrifugations steps required 
for other electron microscopy  techniques36. On the other hand, the cryo-TEM is a powerful tool to distinguish 
a large variety of EVs with different morphology and  sizes37, including OMVs from Gram negative  bacteria3,38 
or MVs from Gram-positives, such as Streptococcus pneumoniae39; as far as we could find, this is the first time 
that lactobacilli EVs are visualized using this technique. Additionally, the good resolution of cryo-TEM images 
allowed the size quantification of the EVs. For L. plantarum BGAN8 the vesicle size was variable, predominantly 
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Figure 4.  Inhibitors of clathrin-mediated endocytosis block internalization of L. plantarum EVs in HT29 cells. 
(A) The left panel shows the vesicle uptake in the absence of endocytosis inhibitors: HT29 cells incubated with 
rhodamine B-R18-labeled EVs (1 μg/well) from L. plantarum (red circles); controls: EVs (grey squares) and 
HT29 cells (brown triangles). The right panels show the uptake of L. plantarum EVs in the presence of inhibitors 
of endocytosis pathways: HT29 cells pre-incubated (prior to the addition of rhodamine B-R18-labeled EVs) 
with the lipid raft disrupting agents filipin III (blue diamonds) or nystatin (green triangles), or with the clathrin-
mediated endocytosis (CME) inhibitors chlorpromazine (yellow triangles) or dynasore (purple diamonds). The 
uptake in the absence of inhibitors is shown as a control (red circles). Fluorescence intensity was normalized 
by fluorescence detected at the indicated time points by labelled EVs in the absence of HT29 cells. Data are 
presented as means ± standard error from three independent experiments. Statistical differences were assessed 
using one-way ANOVA followed by Tukey’s test: *, significance against untreated control cells (p ≤ 0.001); **, 
significance against uptake values in the absence of inhibitors (p ≤ 0.012). (B) Visualization of internalized EVs 
by confocal fluorescence microscopy in the absence (no inhibitor) and the presence of the inhibitors dynasore 
and nystatin after 1 h and 4 h of incubation. Control cells: HT29 in the absence of EVs. Nuclei were stained 
with DAPI (blue), the cell membrane with WGA-Alexa Fluor-488 (green) and internalized EVs with rhodamine 
B-R18-label (red). Scale bar: 20 μm.
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in the 20–60 nm range. When comparing with other bacterial EVs, it is worth noting that the size calculation 
is highly dependent on the measurement method. In any case, variable size distribution of extracellular vesicles 
have been reported for Gram-positive bacterial EVs other than  lactobacilli40, but also for a number of Lactobacil-
lus  species16,24–27,29,41,42. Given the scarce literature, it cannot be postulated if the size distribution of lactobacilli 
EVs could be a strain-specific or a species-associated characteristic and whether culturing or environmental 
conditions could influence the release of these structures.
The proteomic analysis carried out showed that most proteins found in the EVs released by L. plantarum 
BGAN8 were predicted to be located in the membrane (Fig. 3B: 45.3% for EVs-total) which is the main loca-
tion found in the exclusive fraction of the vesicles (91.5%). In the case of the whole bacterial extract, both total 
and exclusive fractions, proteins with cytoplasmic location were the most abundant (50.1% and 64.3%, respec-
tively). Membrane-enriched and cytoplasmic-depleted subcellular locations were also found in the proteomic 
characterization of OMVs from Pseudomonas aeruginosa43 and Escherichia coli44. In the case of Gram-positives, 
extracellular (cell wall, membrane or secreted) and periplasmic location constituted the 63% of the identified 
proteins (vs. 47% cytoplasmatic) in EVs from Streptococcus suis45. Li and co-workers29 found that over half of the 
proteins present in EVs released by L. plantarum WCFS1 were found to be associated with membrane. Elevated 
levels of secreted, cell-wall associated and membrane categorised proteins in EVs released from three strains of 
Lactobacillus acidophilus, L. casei (Lacticaseibacillus casei) and L. reuteri (Limosilactobacillus reuteri) were also 
 reported24. On the contrary, in the L. casei BL23 strain most of the proteins of the EVs were reported to have 
cytoplasmatic  location26. This feature could be related to the distinct cargo molecules that EVs released from 
different species could  harbour4, or to the specificity and accuracy of the different EVs isolation methods. In fact, 
the capability of EVs from Lactobacillus crispatus BC3 and Lactobacillus gasseri BC12 to ex vivo protect vaginal 
tissues from HIV-1 infection was due to the presence of specific proteins and/or metabolites able to inhibit the 
virus, since this effect was not observed for EVs released from other vaginal  lactobacilli42. Apart from the cellular 
location, proteins participating in a broad array of biological processes, such as cell division, communication or 
biogenesis, cellular homeostasis or regulation, but, mainly, metabolic pathways and transport, were identified 
in the EVs from L. plantarum BGAN8 (Fig. 3B). As expected, similar functional classification was found in the 
proteome of other bacterial extracellular vesicles, in spite of the different approaches for data  analysis24–26. The 
EVs from L. plantarum BGAN8 are enriched in proteins associated with transport events. An in-deep analysis 
of the 43 proteins exclusively detected in EVs located in the membrane with assigned function, showed that 17 
were involved in transport; eight of them (Numbers: 449, 745, 841, 886, 1203, 1250, 1274 and 1300; see supple-
mentary data file) are predicted to be amino acid/oligo-peptide transporters. This supports the results obtained 
from SDS-PAGE since bands 2 and 4 (Fig. 3B amino acid/peptide ABC transporters) were highly enriched in 
the EVs extract. The remaining transporters exclusively found in the EVs are predicted to be involved in the 
transport of glycerol (Number 987), niacin (Number 1387) and nucleosides (Numbers 1018 and 1270) or are 
permease-like proteins (Numbers 843, 1143, 1152 and 1303). Interestingly also a protein identified as belonging 
to a polysaccharide biosynthesis family [Number 1125, Pfam IDs: f01943 (integral membrane protein implicated 
in production of polysaccharide), Pf03023 (lipid II flippase), Pf14667 (C-terminal integral membrane region of 
polysaccharide biosynthesis proteins)] was identify in the EVs of this EPS-producing strain. This protein could 
be part of the Wzx (flippase-like protein)—Wzy (polymerase) system that translocates the lipophilic-carrier 
linked EPS-repeating unit of monosaccharides across the cell membrane to build the  polymer32. Then, this could 
support the microscopic observation that EPSs synthesized by L. plantarum BGAN8 seem to be a component 
of their EVs. Nevertheless, the presence of EPSs as structural component of the EVs released by the lactobacilli 
must be proven with additional experimentation procedures.
Inhibitors of clathrin‑mediated endocytosis block the internalization of L. plantarum EVs in 
HT29 cells. In non-phagocytic cells the entrance of small molecules across the membrane bilayer of a cell 
is achieved by four mechanisms: macropinocytosis, clathrin-mediated endocytosis (CME), caveolin-medi-
ated endocytosis, and non‐caveolin/non-clathrin-mediated endocytosis (using lipid rafts or direct membrane 
fusion); all of them have been described as pathways for the uptake of OMVs from Gram-negative  bacteria13. In 
fact, OMVs internalization is mainly driven by endocytosis and the specific pathway depends on the surface and 
cargo of the  vesicles46. To the best of our knowledge, the pathway(s) involved in the uptake of EVs secreted by 
Lactobacillus spp. has not been reported so  far6. In this work we have first showed that intestinal epithelial cells 
are able to internalize EVs released from L. plantarum BGAN8 and that the uptake kinetics by non-polarized 
HT29 was slower than that reported for vesicles of Gram-negative probiotics. In the same cellular model, the 
OMVs from the probiotic strain E. coli Nissle 1917 were intracellularly observed at earlier incubation times, less 
than 1 h46, whereas the EVs from L. plantarum BGAN8 required more time. The delayed kinetics of EVs entry 
may be attributed to a trapping effect of the abundant secreted EPS material (see supplementary Fig. S5) that 
accompanied isolated EVs. Alternatively, the EPS layer that seems to remain in the cover of EVs (see supplemen-
tary Fig. S1) may somehow restrict or defer their binding to specific host cell membrane structures required for 
CME. An elegant way to unequivocally demonstrate whether EPS are forming part of EVs and if in this form are 
responsible for the delayed uptake by intestinal cells would be the use of isogenic non-EPS producing mutants. 
However, to date, this has been an unsuccessful strategy given that it was not possible to genetically manipulate 
this wild type L. plantarum strain.
Secondly, we have studied the EVs internalization pathways by using inhibitors of the three endocytic-
mediated processes, specifically: filipin III and nystatin that inhibit lipid rafts and caveolae pathways, and chlor-
promazine and dynasore that act upon CME, the last one acting upon the protein dynamin required for mem-
brane remodelling and excision of clathrin-coated  vesicles13,47. Our results showed that the EVs released by L. 
plantarum BGAN8 were internalized by the CME pathway, since no uptake was observed using chlorpromazine 
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and dynasore, whereas EVs were still internalized in the presence of inhibitors directed to lipid rafts. There is not 
much data available about the uptake mechanism of EVs from Gram-positive bacteria by host cells, although it 
has been reported that this event occurs, as in the case of S. pneumoniae EVs that are internalized by immune 
 cells39. The four non-phagocytic mediated mechanisms described above have been reported for the internaliza-
tion of OMVs released by Gram-negative bacteria into epithelial cells. The most frequent mechanism involves 
lipid rafts; in addition, the interaction with specific PRR, such as TLR2, also facilitates the entry of  OMVs12,18. 
Lipid rafts are micro-domains within the plasma membrane of eukaryotic cells that have more abundance of 
protein receptors and sphingolipids, which affect its fluidity (less fluid), and are also enriched in cholesterol that 
is required for endocytosis  trafficking48. We could hypothesize that the EPSs layer surrounding the EVs of L. 
plantarum BGAN8, together with the presence of a thick cell wall, could hinder the interaction of the bacterial 
membrane with lipid rafts microdomains. On the contrary, the interaction of the EVs with an unknown recep-
tor could trigger the progressive and sequential assembly of clathrin molecules, forming pits that deform the 
membrane which finally collapses forming the intracellular  vesicle13,48. Therefore, our findings show that the 
internalization of L. plantarum EVs is mediated, at least in part, through CME and suggest that it may be some-
how modulated by the associated EPS. However, the precise mechanism still remains to be totally elucidated. In 
fact, certain bacterial EVs have been shown to use more than one pathway to enter epithelial cells depending on 
the vesicle size (reviewed by O’Donoghue &  Krachler13). In our case, the EVs purified from cultures of L. plan-
tarum BGAN8 are entrapped in a network of EPSs released to the culture medium, which have co-precipitated 
with the EVs (supplementary Fig. S5). The polymeric material created a big volume layer around the vesicles. 
Therefore, macropinocytosis process could be also involved in the uptake of these EV gulps. This hypothesis 
deserves additional experiments to be demonstrated.
Conclusion
Extracellular vesicles mediate cell–cell interactions within and between cells from different kingdoms. EVs 
have been extensively studied in eukaryotic cells, where they have been found to perform important functions 
in modulating physiological conditions. These functions are triggered by the cargo of macromolecules present 
inside the vesicles, mainly proteins and nucleic acids. However, much less attention has been paid to the study 
of bacterial EVs, specifically from non-pathogenic Gram-positives. In the last decade there are several works 
showing that these bacterial structures can carry DNA, RNA, proteins or toxins and play important roles in the 
communication between bacteria and with host cells, such as gene transfer events, modulation of immunity and 
contribution to pathogenesis. In relation to this, the experimental work carried out in our study demonstrated 
that L. plantarum BGAN8 produces EVs containing a pool of exclusive proteins which is highly enriched in 
membrane proteins and in proteins involved in cell processes linked to the cell surface, in comparison with the 
whole cell protein content. In addition, L. plantarum BGAN8 EVs can be taken up by intestinal epithelial cells 
by more than one pathway. In this context inhibitors of CME inhibited the uptake of these EVs into enterocytes, 
suggesting that their internalization is carried out through a clathrin-related pathway. Our results also suggest 
that this uptake could be somehow regulated by the presence of EPS, since this polymer seems to be linked to 
the vesicle structure. However, more experiments are needed to prove that EPS are truly components of EVs. On 
the other hand, macropinocytosis may account for the uptake of large vesicle gulps surrounded by secreted EPS. 
Further studies will also determine the biological processes in which this L. plantarum EVs may be involved.
Methods
EVs purification. L. plantarum BGAN8, belonging to the LMM-IMGGE culture collection, was grown in 
MRS broth (Difco, BD Biosciences, San Diego, CA) at 30 °C for 20 h to early stationary phase. Growth was moni-
tored by continuous measurement of pH (ORION Versa Star, Thermo Scientific Inc., USA), and by measuring 
the optical density  (OD600 nm) and viable bacteria cell counts on agar-MRS at defined points (Fig. S8). Extracel-
lular vesicles (EVs) were isolated as previously described with minor  modifications46. In brief, BGAN8 grown 
cultures (1 L each) were centrifuged (10,000×g, for 20 min, at 4 °C) to collect bacterial pellets and supernatants. 
The last were filtrated, through 0.45 μm-pore size cellulose acetate membranes (Merck, Darmstadt, Germany), 
and concentrated using the Centricon Plus-70 membrane Ultracel-PL, 100 kDa cutoff (Millipore, Merck) follow-
ing the manufacturer’s instructions. Concentrated supernatants were centrifuged at 260,000×g for 1 h at 4 °C and 
washed twice with phosphate buffered saline solution (PBS), or with 0.1 M phosphate buffer without salts (PB). 
The sediments containing EVs were resuspended in PBS and stored at − 20 °C for further experiments, or were 
resuspended in PB and stored at 4 °C for microscopic analyses.
For proteomic analyses, bacterial pellets were used to obtain the whole cell-extracts (fraction named BGAN8). 
For this, cell pellets were washed and concentrated 10-times in PBS, followed by cell-disruption in a French 
Press (Mini Cell Pressure Cell 3.7 for French Press G-M) at 2.5 kbar through three passages. After disruption, 
samples were centrifuged at 16,000×g, for 5 min at 4 °C to collect the supernatants which were kept at − 20 °C 
until their use. The protein content of both, isolated EVs and whole BGAN8 cell-extracts, was measured by Pierce 
BCA Protein Assay Kit (Thermo Fisher Scientific, Waltham, Massachusetts, USA) following the manufacturer’s 
instructions. These procedures were repeated three times (from three independent cultures of the BGAN8 strain).
Microscopically analysis of L. plantarum BGAN8. Transmission electron microscopy (TEM) and 
scanning electron microscopy (SEM) of fresh cultures of L. plantarum BGAN8 were done at the “Scientific-tech-
nical services” of the University of Oviedo (Asturias), following standard procedures. Cryo-SEM was done at the 
“Electron Microscopy Service” of the Institute of Marine Sciences (ICM-CSIC, Barcelona). See supplementary 
material for detailed methodology.
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Microstructural analysis of EVs. Cryo-transmission electron microscopy (Cryo-TEM) analysis was per-
formed with fresh (4 °C stored) EVs samples as described  previously38. Briefly, one drop of the sample diluted 
1/5 in milliQ water was applied on the carbon surface of a glow-discharged Lacey Carbon 300 mesh copper grid 
(Ted Pella, USA). The sample was allowed to adsorb for 1 min, at 100% humidity, inside the chamber Vitrobot 
Mark III (FEI Company, Eindhoven, Netherlands). The excess of liquid was automatically blotted with filter 
paper, followed by cryo-immobilization by plunge freezing in liquefied ethane. The vitrified sample was stored 
in liquid nitrogen until its observation in the cryo-TEM microscope. Plunge-frozen sample was transferred to a 
Tecnai F20 EM (FEI Companys) using a cryo-holder system (Gatan, Pleasanton, USA). The sample was exam-
ined at 200 kV, at a temperature ranging from − 179 to − 170 °C, using low-dose imaging conditions. Low-dose 
images were recorded with a 4096 × 4096-pixel CCD Eagle camera (FEI Company). This analysis was carried out 
at the Cryo-Electron Microscopy Unit of the Science and Technological Centres at the University of Barcelona 
(CCiT-UB).
Protein fingerprinting. Protein profile of EVs and cell-extracts was analysed by 10% SDS-PAGE using 
20 μg protein from each extract of the three replicates. Several bands were excised and identified by peptide 
fingerprint and fragmentation following comparison with the NCBIprot database (Inbiotec, Leon, Spain). In 
addition, PBS-extracts obtained in three independent biological replicates were mixed and analysed by liquid 
chromatography and mass spectrometry (Proteomic Unit, CAI Técnicas Biológicas, U.C.M. Madrid). In short, 
desalted protein digests were analysed by RP-LC–ESI–MS/MS in an EASY-nLC 1000 System coupled to the 
Q-Exactive HF mass spectrometer through the Nano-Easy spray source (all from Thermo Scientific, Missis-
sagua, ON, Canada). Database search was performed against UniProt database (SwissProt and TrEMBL) with 
taxonomic restriction to L. plantarum. Detailed information of these procedures is described in the supplemen-
tary material.
Internalization of EVs into HT29 cell line. The human colonic cell line HT29 (ATCC HTB-38) was 
obtained from the American Type Culture Collection and cultured in DMEM High Glucose (Dulbecco’s Modi-
fied Eagle Medium) supplemented with 10% (v/v) fetal bovine serum, 25 mM HEPES, 1% non-essential amino 
acids, penicillin (100 U/ml) and streptomycin (100 µg/ml). A total number of 1 × 105 intestinal epithelial cells 
were seeded in 96-well plates suitable for fluorescence-based assays and let grown at 37 °C, 5%  CO2, to 80% 
confluence.
EVs were fluorescently labeled with rhodamine isothiocyanate B-R18 (Molecular Probes, Thermo-Fisher 
Scientific) as previously  described46 (see supplementary methods). Fluorescence of this probe is quenched in 
bilayer membranes at high concentration, but it is dequenched when probe is diluted after membrane fusion. 
Rhodamine-labeled EVs were suspended in PBS (0.2 M NaCl) containing a protease inhibitor cocktail and stored 
at 4ºC for up to 6 weeks.
To evaluate L. plantarum EVs uptake, HT29 cells were washed with PBS and incubated with rhodamine 
B-R18-labelled EVs (1 µg protein/well) suspended in DMEM without fetal bovine serum and phenol red. HT29 
monolayers were incubated at 37ºC and fluorescence was measured over time, up to 5 h, in a Modulus-Microplate 
fluorescence reader (Ex 570 nm; Em 595 nm). Fluorescence intensity was normalized by fluorescence emitted by 
labeled-EVs in the absence of HT29 cells. To identify the endocytosis pathway, HT29 cells were pre-incubated for 
1 h at 37 °C with the endocytosis inhibitors dynasore (80 μM), chlorpromazine (15 μg/ml,) filipin III (10 μg/ml) 
or nystatin (10 μg/ml), all reagents purchased from Sigma-Aldrich. Then, rhodamine B-R18-labeled EVs (1 μg 
protein/ well) were added to each well and cells were further incubated at 37 °C measuring the fluorescence over 
time. Control HT29 cells were not pre-treated with the inhibitors. Fluorometric uptake assays were repeated at 
least three independent times in triplicate.
Additionally, confocal fluorescence microscopy was used to confirm the entry pathway and the intracellular 
location of labeled-EVs46. HT29 cells, grown in 8-well chamber slide (Ibidi GmbH, Martinsried, Germany) to 
80% confluence, were incubated with rhodamine B-R18-labeled EVs (2 μg/ well) at 37 °C. After 1 h and 4 h, 
cells were washed with PBS and the nuclei were labeled with DAPI whereas membranes were labeled with Alexa 
Fluor-488 wheat germ agglutinin (WGA, Molecular Probes) (1 μg/ml, 4 °C), after incubation for 25 min, fol-
lowed by fixation for 30 min with 3% paraformaldehyde. Parallel experiments were performed with HT29 cells 
pre-incubated with dynasore (80 μM) or filipin III (10 μg/ml). Fluorescence microscopy was carried out with a 
Leica TCS SP5 laser scanning confocal spectral microscope, using the 63 × oil immersion objective lens. Images 
were captured with a Nikon color camera (16 bit). Fluorescence was recorded at 405 nm (blue, DAPI), 488 nm 
(green, WGA) and 546 nm (red; rhodamine B-R18). Z-stack images were taken at 0.5 to 1.0-μm. The Fiji image 
processing package was used for fluorescence imaging analysis.
Monitoring the effect of EVs on HT29 cell line. The behaviour of HT29 cells in the presence of EVs 
or UV-inactivated L. plantarum BGAN8 bacteria was monitored using the real time cell analyser (RTCA-DP) 
xCelligence (ACEA Bioscience Inc., San Diego, CA, USA) as previously  described49. In short, 16-well E-plates 
(ACEA Bioscience) were seeded (2 × 105 cells in 100 μl culture medium) and placed into the monitoring device, 
which records the impedance signal, to reach a stable value indicating the formation of a monolayer. At this 
point (about 22 ± 1 h of incubation), supernatants were removed and 200 μl culture medium containing different 
concentrations of EVs (from 0.63 μg/ml to 40 μg/ml protein content) or UV-treated bacteria (ratio 10:1, 50:1 and 
100:1, bacteria: HT29 cells) was added. The incubation was monitored for additional 38 h and the impedance 
data were normalized by the control sample (HT29 incubated in the culture medium alone) and by the time at 
which the EVs or inactivated bacteria were added.
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Statistical analyses. Statistical analysis was performed using SPSS (version 20.0, Chicago, IL, USA) soft-
ware package. Quantitative data are presented as mean ± standard error. Differences among treatment groups 
were assessed using one-way ANOVA followed by Tukey’s test (p value < 0.05).
Data availability
Data generated or analysed during this study, as well as detailed protocols and methods, have been made avail-
able in the supplementary section of this article. If additional data presented here is required, it will be made 
available upon request to the corresponding author.
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